Cargando…
Familial Alzheimer’s Disease and Recessive Modifiers
Alzheimer’s disease (AD) is progressive brain disorder that affects ~ 50 million people worldwide and has no current effective treatment. AD age of onset (ADAOO) has shown to be critical for the identification of genes that modify the appearance of AD signs and symptoms in a specific population. We...
Autores principales: | Vélez, Jorge I., Lopera, Francisco, Silva, Claudia T., Villegas, Andrés, Espinosa, Lady G., Vidal, Oscar M., Mastronardi, Claudio A., Arcos-Burgos, Mauricio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031188/ https://www.ncbi.nlm.nih.gov/pubmed/31664702 http://dx.doi.org/10.1007/s12035-019-01798-0 |
Ejemplares similares
-
A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's Disease
por: Vélez, Jorge I., et al.
Publicado: (2016) -
A Comprehensive Machine Learning Framework for the Exact Prediction of the Age of Onset in Familial and Sporadic Alzheimer’s Disease
por: Vélez, Jorge I., et al.
Publicado: (2021) -
Targeting Neuroplasticity, Cardiovascular, and Cognitive-Associated Genomic Variants in Familial Alzheimer’s Disease
por: Vélez, Jorge I., et al.
Publicado: (2018) -
Neural Plasticity during Aging
por: Arcos-Burgos, Mauricio, et al.
Publicado: (2019) -
A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer’s disease
por: Sepulveda-Falla, Diego, et al.
Publicado: (2020)